Biotricity, Inc.
BTCY
$0.48
-$0.02-4.02%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.30% | 4.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.30% | 4.63% | |||
| Cost of Revenue | -6.99% | 4.53% | |||
| Gross Profit | 2.08% | 4.65% | |||
| SG&A Expenses | 7.77% | -34.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.56% | -21.20% | |||
| Operating Income | -2.87% | 132.95% | |||
| Income Before Tax | -2.81% | 65.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.81% | 65.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.81% | 65.28% | |||
| EBIT | -2.87% | 132.95% | |||
| EBITDA | -2.86% | 133.19% | |||
| EPS Basic | -0.70% | 62.58% | |||
| Normalized Basic EPS | 0.62% | 64.94% | |||
| EPS Diluted | -1.05% | 62.68% | |||
| Normalized Diluted EPS | 0.62% | 64.94% | |||
| Average Basic Shares Outstanding | 1.84% | -0.25% | |||
| Average Diluted Shares Outstanding | 1.84% | -0.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.01% | -1.79% | |||